{"doi":"10.1093/alcalc/36.1.2","title":"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism","abstract":null,"journal":"Alcohol and Alcoholism","year":2001,"id":26103,"datarank":8.25611640307636,"base_score":5.159055299214529,"endowment":5.159055299214529,"self_citation_contribution":0.7738582948821795,"citation_network_contribution":7.4822581081941815,"self_endowment_contribution":0.7738582948821795,"citer_contribution":7.4822581081941815,"corpus_percentile":null,"corpus_rank":null,"citation_count":173,"citer_count":169,"citers_with_citation_signal":139,"citers_with_endowment":139,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":151799,"name":"J. D. Sinclair","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.159055299214529,"endowment":5.159055299214529,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"11139409","pmcid":null,"openalex_id":"https://openalex.org/W2107677036","authors":[],"funders":[],"total_grants":0,"fwci":6.3743,"citation_percentile":0.97183821,"influential_citations":11,"citation_trend":[{"year":2012,"count":4},{"year":2013,"count":5},{"year":2014,"count":4},{"year":2015,"count":10},{"year":2016,"count":9},{"year":2017,"count":6},{"year":2018,"count":2},{"year":2019,"count":4},{"year":2020,"count":10},{"year":2021,"count":4},{"year":2022,"count":4},{"year":2024,"count":3},{"year":2025,"count":4},{"year":2026,"count":3}],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://academic.oup.com/alcalc/article-pdf/36/1/2/9736756/360002.pdf","host_type":"journal"},{"url":"https://academic.oup.com/alcalc/article-pdf/36/1/2/9736756/360002.pdf","host_type":"BRONZE"},{"url":"https://academic.oup.com/alcalc/article-pdf/36/1/2/9736756/360002.pdf","host_type":"publisher"},{"url":"http://academic.oup.com/alcalc/article-pdf/36/1/2/9736756/360002.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1093/alcalc/36.1.2","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/11139409","host_type":"repository"}],"fields_of_study":["Substance Abuse Treatment and Outcomes","Neurotransmitter Receptor Influence on Behavior","Opioid Use Disorder Treatment","Medicine","Psychology","Alcoholism","Animals","Behavior, Addictive","Humans","Naltrexone","Narcotic Antagonists","Rats","Temperance"],"mesh_terms":["Alcoholism","Animals","Humans","Naltrexone","Narcotic Antagonists","Temperance","Behavior, Addictive","Rats"],"keywords":["Naltrexone","Narcotic antagonist","Abstinence","Placebo","Nalmefene","Relapse prevention","Clinical trial","Psychology","Opioid antagonist","Medicine","Alcohol dependence","Psychiatry","Extinction (optical mineralogy)","(+)-Naloxone","Anesthesia","Opioid","Internal medicine","Alcohol","Alternative medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T11:38:06.003850Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}